Drug Master Files for: propoxyphene napsylate
✉ Email this page to a colleague
propoxyphene napsylate Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
1350 | I | II | 4/24/1969 | DINAMITE DIPHARMA SPA | PROPOXYPHENE HYDROCHLORIDE |
1381 | I | II | 7/1/1969 | VICTOR M HERMELIN CO DIV K-V PHARMACAL CO | DARVON (PROPOXYPHENE HCL) SUSTAINED RELEASE CAPSULES |
14004 | I | II | 2/26/1999 | MALLINCKRODT INC THE PHARMACEUTICALS BUSINESS OF COVIDIEN | PROPOXYPHENE HYDROCHLORIDE USP POWDER (E SUB) |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information